Custos Family Office’s Merck MRK Stock Holding History

Custos Family Office’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$218K	Buy	+2,068	New	+$194K	0.15%	56

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Custos Family Office's MRK Position: Q4 2025 in Review

Custos Family Office opened a new position in Merck (MRK) in Q4 2025: 2,068 shares worth $218K. The stake represents 0.15% of the portfolio and ranks #56 among its holdings.

3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Custos Family Office held 2,068 shares of Merck worth $218K as of Q4 2025.
Merck was a new Custos Family Office position in Q4 2025.
Merck made up 0.15% of Custos Family Office's portfolio in Q4 2025, its #56 holding.
3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Custos Family Office's 13F filing for Q4 2025, filed 17 Feb 2026.